Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03106077
Brief Title: Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer

First Submitted : April 4, 2017
First Submitted that Met QC Criteria : April 4, 2017
First Posted : April 10, 2017

Results First Submitted : October 1, 2020
Results First Submitted that Met QC Criteria : October 27, 2020
Results First Posted : November 19, 2020

Last Update Submitted that Met QC Criteria : November 18, 2020
Last Update Posted : December 2, 2020